Share this

Summary

References

  1. European Centre for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases. Invasive pneumococcal disease. Accessed 26 September 2025. https://atlas.ecdc.europa.eu/public/index.aspx.
  2. Centers for Disease Control and Prevention. (2024). ABCs bact facts interactive data dashboard: SPN serotypes 1998–2023. Accessed 26 September 2025. https://www.cdc.gov/abcs/bact-facts/data-dashboard.html.
  3. Prevenar 20 SmPC.
  4. Prevenar 13 SmPC.
  5. Kobayashi, M., Leidner, A. J., Gierke, R.,et al. (2025) Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged ≥50 years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024. Morbidity and Mortality Weekly Report, 74(1), 1–9.
  6. Centers for Disease Control and Prevention. (2024). ABCs bact facts interactive data dashboard: SPN serotypes 1998–2023. Accessed 26 September 2025. https://www.cdc.gov/abcs/bact-facts/data-dashboard.html.
  7. Centers for Disease Control and Prevention. (2025). 1998–2023 serotype data for invasive pneumococcal disease cases by age group from Active Bacterial Core surveillance: Ages 18–49, 50–64, 65+. Accessed 26 September https://data.cdc.gov/Public-Health-Surveillance/1998-2023-Serotype-Data-for-Invasive-Pneumococcal-/qvzb-qs6p/data_preview.

AE-NON-00601 | Expiry Date: 26/09/2027